Petlife Pharmaceuticals, Inc.
PTLF
$0.0001
$0.000.00%
| 02/28/2018 | 11/30/2017 | 08/31/2017 | 05/31/2017 | 02/28/2017 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 17.90K | 17.90K | 17.90K | -- | -- |
| Gross Profit | -17.90K | -17.90K | -17.90K | -- | -- |
| SG&A Expenses | 2.39M | 3.47M | 22.39M | 24.26M | 23.81M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.41M | 3.48M | 22.40M | 24.26M | 23.81M |
| Operating Income | -2.41M | -3.48M | -22.40M | -24.26M | -23.81M |
| Income Before Tax | -3.71M | -4.60M | -23.25M | -24.57M | -23.88M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.71 | -4.60 | -23.25 | -24.57 | -23.88 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.71M | -4.60M | -23.25M | -24.57M | -23.88M |
| EBIT | -2.41M | -3.48M | -22.40M | -24.26M | -23.81M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.04 | -0.06 | -0.94 | -1.26 | -1.26 |
| Normalized Basic EPS | -0.02 | -0.04 | -0.58 | -0.78 | -0.79 |
| EPS Diluted | -0.04 | -0.06 | -0.94 | -1.26 | -1.26 |
| Normalized Diluted EPS | -0.02 | -0.04 | -0.58 | -0.78 | -0.79 |
| Average Basic Shares Outstanding | 355.93M | 326.06M | 273.83M | 138.77M | 83.86M |
| Average Diluted Shares Outstanding | 355.93M | 326.06M | 273.83M | 138.77M | 83.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
